Condition
Treatment-resistant Schizophrenia clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Treatment-resistant Schizophrenia clinical trials that are recruiting, at sites in 11 countries (most in United States (2), France (1), Denmark (1)). 1 was first registered in the last 30 days. By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1New in 30 days
- 11Countries
Newest Treatment-resistant Schizophrenia clinical trials
All recruiting trials (9)
-
Sequential Treatment Approaches for Treatment-Resistant Schizophrenia in Chinese Patients
This trial tests whether clozapine-based drug therapy or neuromodulation with MECT or MST is better for adults in China who have treatment-resistant schizophrenia.
-
Nitraria Retusa Infusion for Clozapine-Related Metabolic Side Effects in Treatment-Resistant Schizophrenia
A daily Nitraria retusa leaf infusion is tested for 90 days to see if it helps with metabolic side effects in people with treatment-resistant schizophrenia who are taking clozapine.
-
Evenamide added to standard antipsychotic treatment for treatment-resistant schizophrenia
This 12-week randomized, double-blind test will see if adding evenamide (15 mg twice daily) to a patient’s current antipsychotic helps adults with treatment-resistant schizophrenia improve symptoms compared with placebo.
-
Cognitive Behavioral Therapy for Sleep Issues in Schizophrenia
This study tests if a special type of therapy for sleep problems can help people with schizophrenia who have trouble sleeping feel better and improve their overall quality of life.
-
Magnetic seizure therapy versus electroconvulsive therapy for treatment‑resistant schizophrenia
This trial will test whether magnetic seizure therapy works as well as a specific form of electroconvulsive therapy for adults whose schizophrenia or schizoaffective disorder has not improved with medications.
-
Using maintenance electroconvulsive therapy for treatment-resistant schizophrenia
This study is testing if adding maintenance electroconvulsive therapy to clozapine can help people with treatment-resistant schizophrenia stay well longer and improve their quality of life.
-
Reducing auditory-verbal hallucinations in schizophrenia using brain stimulation
This study is testing a new brain stimulation method to see if it can help people with schizophrenia who hear voices and haven't found relief with regular medications.
-
Neurofeedback treatment for schizophrenia patients with auditory hallucinations
This study is testing if a special brain training method can help people with schizophrenia who hear voices feel better by changing how their brain works.
-
Evaluation of the redevelopment of Ireland's National Forensic Mental Health Service
This study is testing how moving to a new 170-bed mental health hospital in Ireland affects the recovery and care of patients with mental health issues involved in the justice system.
Related topics
Quick answers
How many Treatment-resistant Schizophrenia clinical trials are recruiting right now?
9, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (2 trials), France (1 trial), Denmark (1 trial), Canada (1 trial), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.